Advertisement
Screener

ProPhase Labs, Inc. (PRPH) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

ProPhase Labs, Inc. Shares Authorized

ProPhase Labs, Inc. (PRPH) had Shares Authorized of 1.00 billion shares as of 2026-06-30, per its 10-Q filed 2026-08-19.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-19

  • 2026-06-30: Common Stock, Shares Authorized 1.00B shares.
  • 2026-03-31: Common Stock, Shares Authorized 1.00B shares.
  • 2025-12-31: Common Stock, Shares Authorized 1.00B shares.
  • 2025-09-30: Common Stock, Shares Authorized 1.00B shares.
Period endCommon Stock, Shares AuthorizedCommon Stock, Shares Authorized as first filed
2026-06-301.00B shares
10-Q · filed 2026-08-19
2026-03-311.00B shares
10-Q/A · filed 2026-07-09
2025-12-311.00B shares
10-Q · filed 2026-08-19
2025-09-301.00B shares
10-Q · filed 2025-11-19
2025-09-091.00B shares
10-K · filed 2026-06-01
2025-09-0850.00M shares
10-K · filed 2026-06-01
2025-06-3050.00M shares
10-Q · filed 2025-08-13
2025-03-3150.00M shares
10-Q · filed 2025-05-20
2024-12-311.00B shares
10-K · filed 2026-06-01
50.00M shares
10-K · filed 2025-04-01
2024-09-3050.00M shares
10-Q · filed 2024-11-13
2024-06-3050.00M shares
10-Q · filed 2024-08-14
2024-03-3150.00M shares
10-Q · filed 2024-05-10
2023-12-3150.00M shares
10-K · filed 2025-04-01
2023-09-3050.00M shares
10-Q · filed 2023-11-13
2023-06-3050.00M shares
10-Q · filed 2023-08-11
2023-03-3150.00M shares
10-Q · filed 2023-05-12
2022-12-3150.00M shares
10-K · filed 2024-03-29
2022-09-3050.00M shares
10-Q · filed 2022-11-10
2022-06-3050.00M shares
10-Q · filed 2022-08-12
2022-03-3150.00M shares
10-Q · filed 2022-05-13
2021-12-3150.00M shares
10-K · filed 2023-03-29
2021-09-3050.00M shares
10-Q · filed 2021-11-12
2021-06-3050.00M shares
10-Q · filed 2021-08-13
2021-03-3150.00M shares
10-Q · filed 2021-05-14
2020-12-3150.00M shares
10-K · filed 2022-03-31
2020-09-3050.00M shares
10-Q · filed 2020-11-19
2020-06-3050.00M shares
10-Q · filed 2020-08-11
2020-03-3150.00M shares
10-Q · filed 2020-05-12
2019-12-3150.00M shares
10-K · filed 2021-03-31
2019-09-3050.00M shares
10-Q · filed 2019-11-12
2019-06-3050.00M shares
10-Q · filed 2019-08-12
2019-03-3150.00M shares
10-Q · filed 2019-05-14
2018-12-3150.00M shares
10-K · filed 2020-03-26
2018-09-3050.00M shares
10-Q · filed 2018-11-14
2018-06-3050.00M shares
10-Q · filed 2018-08-20
2018-03-3150.00M shares
10-Q/A · filed 2018-08-20
2017-12-3150.00M shares
10-K · filed 2019-03-26
2017-09-3050.00M shares
10-Q/A · filed 2018-08-20
2017-06-3050.00M shares
10-Q/A · filed 2018-08-20
2017-03-3150.00M shares
10-Q/A · filed 2018-08-20
2016-12-3150.00M shares
10-Q/A · filed 2018-08-20
2016-09-3050.00M shares
10-Q · filed 2016-11-14
2016-06-3050.00M shares
10-Q · filed 2016-08-11
2016-03-3150.00M shares
10-Q · filed 2016-05-13
2015-12-3150.00M shares
10-K · filed 2017-02-24
2015-09-3050.00M shares
10-Q · filed 2015-11-13
2015-06-3050.00M shares
10-Q · filed 2015-08-12
2015-03-3150.00M shares
10-Q · filed 2015-05-13
2014-12-3150.00M shares
10-K · filed 2016-03-29
2014-09-3050.00M shares
10-Q · filed 2014-11-13
2014-06-3050.00M shares
10-Q · filed 2014-08-12
2014-03-3150.00M shares
10-Q · filed 2014-05-12
2013-12-3150.00M shares
10-K · filed 2015-03-27
2013-09-3050.00M shares
10-Q · filed 2013-11-13
2013-06-3050.00M shares
10-Q · filed 2013-08-13
2013-03-3150.00M shares
10-Q · filed 2013-05-10
2012-12-3150.00M shares
10-K · filed 2014-03-27
2012-09-3050.00M shares
10-Q · filed 2012-11-14
2012-06-3050.00M shares
10-Q · filed 2012-08-13
2012-03-3150.00M shares
10-Q · filed 2012-05-11
2011-12-3150.00M shares
10-K · filed 2013-03-28
50.00B shares
10-K · filed 2012-03-07
2011-09-3050.00M shares
10-Q · filed 2011-11-14
2011-06-3050.00M shares
10-Q · filed 2011-08-12
2010-12-3150.00B shares
10-K · filed 2012-03-07
50.00M shares
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Pulmatrix, Inc. (PULM)United States$0.006B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26